INMB Earnings

Quarterly EPS
$-0.60
Q3 2024
$-0.41
Q4 2024
$-0.43
Q1 2025
$-1.05
Q2 2025
$-0.24
Q3 2025
$-0.20
Q4 2025
$-0.20
Q1 2026
$-0.05
Q2 2026
Latest RevenueN/A
Latest Net Income-1273000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.050-1273000+95.2%
Q1 2026-$0.200-5407000-100.0%+53.5%
Q4 2025-$0.200-5264000+51.2%
Q3 2025-$0.240-6472000+60.0%
Q2 2025-$1.050-24458000-110.0%
Q1 2025-$0.4350.0K-9739000+257.1%+29.5%
Q4 2024-$0.410-9218000-100.0%+12.8%
Q3 2024-$0.600-12093000-100.0%-25.0%
Q2 2024-$0.500-9746000
Q1 2024-$0.6114.0K-11025000
Q4 2023-$0.4728.0K-8408000
Q3 2023-$0.4843.0K-8563000
INmune Bio (INMB) — Earnings